Neurotoxicity of Acyclovir in Patients With End-Stage Renal Failure Treated With Continuous Ambulatory Peritoneal Dialysis

Bridgen, 1983, The mechanism of action, pharmacokinetics and toxicity of acyclovir—A review, J Infect, 6, 3 Hopefl, 1983, The clinical use of intravenous acyclovir, Drug Intell Clin Pharmacy, 17, 623, 10.1177/106002808301700902 Keeney, 1982, Acyclovir tolerance in humans, Am J Med, 73, 176, 10.1016/0002-9343(82)90086-9 Wade, 1983, Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation, Ann Intern Med, 98, 921, 10.7326/0003-4819-98-6-921 Tomson, 1985, Psychiatric side-effects of acyclovir in patients with chronic renal failure, Lancet, 2, 385, 10.1016/S0140-6736(85)92517-6 1991, 1748 Bataille, 1985, Psychiatric side-effects with acyclovir, Lancet, 2, 724, 10.1016/S0140-6736(85)92960-5 Rubin, 1987, Overdose with acyclovir in a CAPD patient, Perit Dial Bull, 7, 42, 10.1177/089686088700700111 Pettersson, 1985, Prophylactic oral acyclovir after renal transplantation, Transplantation, 39, 279, 10.1097/00007890-198503000-00014 McDermott, 1978, Brain aluminium concentration in dialysis encephalopathy, Lancet, 1, 901, 10.1016/S0140-6736(78)90681-5 Ellenberg, 1990, Cerebrospinal fluid aluminium levels following deferoxamine, Am J Kidney Dis, 16, 157, 10.1016/S0272-6386(12)80572-5 King, 1988, History, pharmacokinetics, and pharmacology of acyclovir, J Am Acad Dermatol, 18, 176, 10.1016/S0190-9622(88)70022-5 Appelboom, 1983, Acyclovir, South Med J, 76, 905, 10.1097/00007611-198307000-00022 Mcdonald, 1989, Lack of toxicity in two cases of neonatal acyclovir overdose, Pediatr Infect Dis, 8, 529, 10.1097/00006454-198908000-00012